Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal notification from the Nasdaq ...

Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced that it has received formal ...

Expanded platform improves access, scales operations, and advances Incannex’s position in next-generation mental health treatmentNEW YORK and MELBOURNE, Australia, June 17, 2025 (GLOBE NEWSWIRE) -- ...

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

Some 7,000 people are expected to attend this week's Psychedelic Science conference in Denver and public health activists are ...

Dr. Salvador Plasencia, an urgent care clinic operator in the Los Angeles area, could face up to 40 years in prison in ...

Early results from a pilot study indicate that psilocybin-assisted therapy could be linked to lower alcohol consumption and ...

Texas Governor Greg Abbott signed Senate Bill 2308, promoting ibogaine research for treating opioid addiction, depression, ...

The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in ...

All OPTIMIZE study participants receive psilocybin, which has been proven to positively impact patients with depression.